Historical record - last NADAC publication: 4/17/2024
Product Information
CEFPODOXIME 50 MG/5 ML SUSP is a generic product labeled by NorthStar Rx LLC, priced at $0.4914 per ML under NDC 16714040201. Its NADAC has been published 53 times since Apr 17, 2024.
Strength
50 mg/5mL
Manufacturer
NorthStar Rx LLCNDC
16714040201
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA065409On Market Since
6/8/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 50 MG/5 ML SUSP has been published 53 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4914 per ML |
|---|---|
| All-time high | $0.4914 (Apr 16, 2025) |
| All-time low | $0.4914 (Apr 17, 2024) |
| Median price | $0.4914 |
| Average price | $0.4914 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 53 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Cefpodoxime Proxetil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFPODOXIME 50 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 50 MG/5 ML SUSP, manufactured by NorthStar Rx LLC, is $0.4914 per ML (NDC 16714040201), effective Apr 16, 2025.
How has the price of CEFPODOXIME 50 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 50 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 50 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for CEFPODOXIME 50 MG/5 ML SUSP has ranged from a low of $0.4914 (Apr 17, 2024) to a high of $0.4914 (Apr 16, 2025), with a median of $0.4914 per ML.
Are there cheaper alternatives to CEFPODOXIME 50 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFPODOXIME 50 MG/5 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures CEFPODOXIME 50 MG/5 ML SUSP?
CEFPODOXIME 50 MG/5 ML SUSP (NDC 16714040201) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification